Smallpox vaccine extends life in cancer trial (Reuters)
Reuters – A genetically engineered smallpox vaccine reduced the risk of death for patients with advanced liver cancer by nearly 60 percent in a mid-stage study, prompting the launch of a later-stage trial.
View full post on Yahoo! News: Health News
Leave a Reply